Switch View
© BusinessWire
06.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity to Hold Earnings Call on Monday, October 27, 2025
News Preview
Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2025 financial results prior to market open on Monday, October 27, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the launch of Twist’s new Trinity Freestyle Fast Hybridization workflow for Element's AVITI™ sequencing platforms, a user-friendly, end-to-end seq...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B
News Preview
OTTAWA, Ontario, Oct. 6, 2025 /CNW/ -- CSL Behring Canada Inc., a business unit of global biopharma leader CSL, today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of HEMGENIX® (etranacogene dezaparvovec). HEMGENIX is the fi...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
06.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health
News Preview
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the launch of a first-of-its-kind Gestational Age artificial intelligence (AI) tool in Malawi and Uganda. The tool is Butterfly’s latest innovation to improve mat...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent industry analysts who recognize that STAAR’s merger with Alcon (SIX/NYSE: ALC) – and the compelling, certain, premium cash value it prov...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the flawed, misleading, and misinformed claims recently made by Broadwood Partners, L.P.:
Broadwood’s recent presentation recycles flawe...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that its Board of Directors has appointed Ian F. Smith as Chief Executive Officer (CEO). Mr. Smith has served as Interim CEO since March 2025 and as a member of Stoke’s Boa...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX Announces Launch of EPIXPRESS®
News Preview
Next-Generation, Lyophilized Human Placental Allograft Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products Next-Generation, Lyophilized Human Placental Allograft Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
News Preview
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced new innovations and products that will be featured at The American Society f...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
News Preview
Over 1,200 participants enrolled in ATMOSPHERE® and ASCENT® pivotal trials, representing largest global gene therapy program ever conducted
Subretinal surabgene lomparvovec on track to be first gene therapy for wet AMD...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025.
“I am pleased to welcome Bilal and Linea to our leadership team as we advance the global launch of EKTERLY,” said Ben Palleiko, Chief Executive Officer of Kal...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA68405H1001
Optimi Health Corp
OPTI
LISTED
CSE
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program
News Preview
Australia's largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSDVancouver, British Columbia--(Newsfile Corp. - October 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GM...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
06.10.2025
ISIN: US28106W1036
Editas Medicine Inc
EDIT
LISTED
NASDAQ
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced an oral presentation at the upcoming European Society of Gene and Cell Therapy (ESGCT) Congress, to be held October 7-10, 2025, in Seville,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics
News Preview
OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD™ near real-time AI powered provider network (“network”) enabling OneMedNet to empower...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials evaluating the safety and efficacy of tulisokibart (MK-7240), an investigational humanized monoclonal antibody targeting tumor necrosis factor (TNF)-like cytokine 1A (TL1A), in patients with three immune-mediated inflammatory d...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
News Preview
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness Signs 1st Ottawa, Ontario Real-Estate Location with Multi-Unit & Multi-Branded Franchisee
News Preview
Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce that an existing multi-unit franchisee of Via Cibo has successfully secured a real estate location for Heal Wellne...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US58468P2065
MediciNova Inc
MNOV
LISTED
NASDAQ
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
News Preview
LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, M.D., Ph.D., President and CEO, and David H. Crean, Ph.D., Chief Business Officer,...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
News Preview
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
News Preview
Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to accelerate time to treatment...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
News Preview
HOUSTON, Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physicia...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
News Preview
NEW HAVEN, Conn., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application and provided feedback to advance the company’s REVOLUTION clinical program, Invivyd’s development program for VYD2311, a vaccine alte...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
News Preview
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
Clinical data from independent investigator-initiated studies using [⁶⁸Ga]Ga-PentixaFor demonstrate potential to improve diagnosis in Primary Aldosteronism
First-in-human findings with [¹⁷⁷Lu]Lu-PentixaTher in bladder cancer show early......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm präsentiert erweiterte CXCR4-Radiopharmazeutika-Plattform mit neuen klinischen Ergebnissen auf EANM 2025 Kongress
News Preview
Pentixapharm präsentiert erweiterte CXCR4-Radiopharmazeutika-Plattform mit neuen klinischen Ergebnissen auf EANM 2025 Kongress
Klinische Daten aus unabhängigen prüferinitiierten Studien mit [⁶⁸Ga]Ga-PentixaFor zeigen Potenzial zur verbesserten Diagnostik des Primären Hyperaldosteronismus (PA)
Erste klinische Ergebnisse mit [¹⁷⁷Lu]Lu-PentixaTh......
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
News Preview
Maze Therapeutics appoints industry veteran Hervé Hoppenot as Chairman of the Board of Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US87583X1090
Tango Therapeutics Inc
TNGX
LISTED
NASDAQ
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
News Preview
Company to present three posters at SITC Annual Meeting 2025 Company to present three posters at SITC Annual Meeting 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
ImprimisRx Announces Leadership Changes
News Preview
Frank Mullery Appointed Chief Executive Officer of ImprimisRx...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDA...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
News Preview
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types. The benchmarking process will help evaluate model prec...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
News Preview
Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce its participation at CPHI Worldwide 2025, taking place in Frankfurt, Germany from October 28-30, 20...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 6, 2025 / Lunai Bioworks (Nasdaq:LNAI) today announced a major advance in Alzheimer's research: its AI platform, Augusta™, achieved up to a 35% improvement in diagnostic accuracy by combining MRI scans with genetic and metabolic data. The company is launching a preclinical Alzheimer's progra...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
News Preview
Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral nutrition and supplementary IV fluids) of approximately 37% SAN FRANCISCO, CA, AL / ACCESS Newswire / October 6, 2025 / Jaguar Health, Inc. (N...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
News Preview
LONDON and REYKJAVIK, Iceland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
News Preview
LONDON, UK and REYKJAVIK, ICELAND (OCTOBER 6, 2025) — Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
DATROWAY® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
News Preview
Positive topline results from the TROPION-Breast02 phase 3 trial showed DATROWAY® (datopotamab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) compared to investigator’s choice of chemotherapy as first-line treatme...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform
News Preview
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
News Preview
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA, CA / ACCESS Newswire / October 6, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology ta...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
News Preview
Clinical data from independent investigator-initiated studies using [⁶⁸Ga]Ga-PentixaFor demonstrate potential to improve diagnosis in Primary AldosteronismFirst-in-human findings with [¹⁷⁷Lu]Lu-PentixaTher in bladder cancer show early therapeutic activity, further validating CXCR4 as a clinically relevant target BERLIN, DE / ACCESS Newswire /...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches new comprehensive chronic kidney disease (CKD) algorithm panel
News Preview
Basel, 6 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with KlinRisk, Inc., has received the CE-mark for the first AI-based risk stratification tool to assess progressive decline in kidney function. This milestone allows Roche to introduce the Chronic Kidney Disease (CKD) algorithm panel on its navify® Algorithm Suite to suppo...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
News Preview
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.MD A...
Themefolio
Profiler
Peergroup
© PR Newswire
05.10.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO
News Preview
NEW YORK, Oct. 5, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.10.2025
ISIN: US04335A1051
Arvinas, Inc.
ARVN
LISTED
NASDAQ
Arvinas Presents Late Breaking, Positive Phase 1 Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
News Preview
– ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease –...
Themefolio
Profiler
Peergroup
© PR Newswire
05.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Lantheus Holdings, Inc. (LNTH)
News Preview
RADNOR, Pa., Oct. 5, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus secur...
Themefolio
Profiler
Peergroup
© PR Newswire
05.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
CLASS ACTION REMINDER: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors to Inquire About a Securities Fraud Lawsuit by October 27, 2025
News Preview
PHILADELPHIA, Oct. 5, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Cl...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.10.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
News Preview
WALTHAM, Mass., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced scienti...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 4, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Do you own shares of MOH? Robbins LLP Informs Investors of the Molina Healthcare, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 3, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025. Molina provides healthcare services to low-income...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
News Preview
NEW ORLEANS, Oct. 3, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have untilNovember 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquir...
Themefolio
Profiler
Peergroup
© BusinessWire
04.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Molina Healthcare, Inc. Shareholders
News Preview
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Hindlemann v. Molina Healthcare, Inc., et al., Case No. 2:25-cv-09461, on behalf of persons and entities that purchased or otherwise acquired Molina Healthcare, Inc. (“Mol...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 3, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDA...
Themefolio
Profiler
Peergroup
© PR Newswire
04.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 3, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 3, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUT...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: US98422E1038
Xeris Biopharma Holdings Inc
XERS
LISTED
NASDAQ
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on October 1, 2025, the Compensation Committee of Xeris’ Board of Directors granted restricted stock units for an aggreg...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 9,390 shares of t...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 3, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK)....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NOVATO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of non-qualified stock options to purchase an aggregate of 62,232 shares of common stock of the...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Publication relating to transparency notifications
News Preview
REGULATED INFORMATION...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
